170 related articles for article (PubMed ID: 22232013)
21. Does serum uric acid act as a modulator of cerebrospinal fluid Alzheimer's disease biomarker related cognitive decline?
Ye BS; Lee WW; Ham JH; Lee JJ; Lee PH; Sohn YH;
Eur J Neurol; 2016 May; 23(5):948-57. PubMed ID: 26917248
[TBL] [Abstract][Full Text] [Related]
22. Increased Serum miR-206 Level Predicts Conversion from Amnestic Mild Cognitive Impairment to Alzheimer's Disease: A 5-Year Follow-up Study.
Xie B; Liu Z; Jiang L; Liu W; Song M; Zhang Q; Zhang R; Cui D; Wang X; Xu S
J Alzheimers Dis; 2017; 55(2):509-520. PubMed ID: 27662297
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of ctr1Δ300, a high-affinity copper transporter with deletion of the cytosolic C-terminus in Saccharomyces cerevisiae under excess copper, leads to disruption of transition metal homeostasis and transcriptional remodelling of cellular processes.
Schuller A; Auffermann G; Zoschke K; Schmidt U; Ostermann K; Rödel G
Yeast; 2013 May; 30(5):201-18. PubMed ID: 23576094
[TBL] [Abstract][Full Text] [Related]
24. Reduced platelet amyloid precursor protein ratio (APP ratio) predicts conversion from mild cognitive impairment to Alzheimer's disease.
Zainaghi IA; Talib LL; Diniz BS; Gattaz WF; Forlenza OV
J Neural Transm (Vienna); 2012 Jul; 119(7):815-9. PubMed ID: 22573143
[TBL] [Abstract][Full Text] [Related]
25. Cerebral Artery Pulsatility is Associated with Cognitive Impairment and Predicts Dementia in Individuals with Subjective Memory Decline or Mild Cognitive Impairment.
Chung CP; Lee HY; Lin PC; Wang PN
J Alzheimers Dis; 2017; 60(2):625-632. PubMed ID: 28826186
[TBL] [Abstract][Full Text] [Related]
26. Neuropsychological Decline Improves Prediction of Dementia Beyond Alzheimer's Disease Biomarker and Mild Cognitive Impairment Diagnoses.
Nation DA; Ho JK; Dutt S; Han SD; Lai MHC;
J Alzheimers Dis; 2019; 69(4):1171-1182. PubMed ID: 31104015
[TBL] [Abstract][Full Text] [Related]
27. Mitochondrial dysfunction and immune activation are detectable in early Alzheimer's disease blood.
Lunnon K; Ibrahim Z; Proitsi P; Lourdusamy A; Newhouse S; Sattlecker M; Furney S; Saleem M; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Coppola G; Geschwind D; Simmons A; Lovestone S; Dobson R; Hodges A;
J Alzheimers Dis; 2012; 30(3):685-710. PubMed ID: 22466004
[TBL] [Abstract][Full Text] [Related]
28. Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type.
Popp J; Wolfsgruber S; Heuser I; Peters O; Hüll M; Schröder J; Möller HJ; Lewczuk P; Schneider A; Jahn H; Luckhaus C; Perneczky R; Frölich L; Wagner M; Maier W; Wiltfang J; Kornhuber J; Jessen F
Neurobiol Aging; 2015 Feb; 36(2):601-7. PubMed ID: 25435336
[TBL] [Abstract][Full Text] [Related]
29. Serum Calcium Predicts Cognitive Decline and Clinical Progression of Alzheimer's Disease.
Ma LZ; Wang ZX; Wang ZT; Hou XH; Shen XN; Ou YN; Dong Q; Tan L; Yu JT
Neurotox Res; 2021 Jun; 39(3):609-617. PubMed ID: 33216282
[TBL] [Abstract][Full Text] [Related]
30. Longitudinal plasma p-tau217 is increased in early stages of Alzheimer's disease.
Mattsson-Carlgren N; Janelidze S; Palmqvist S; Cullen N; Svenningsson AL; Strandberg O; Mengel D; Walsh DM; Stomrud E; Dage JL; Hansson O
Brain; 2020 Dec; 143(11):3234-3241. PubMed ID: 33068398
[TBL] [Abstract][Full Text] [Related]
31. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K
JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028
[TBL] [Abstract][Full Text] [Related]
32. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
[TBL] [Abstract][Full Text] [Related]
33. A New Serum Biomarker Set to Detect Mild Cognitive Impairment and Alzheimer's Disease by Peptidome Technology.
Abe K; Shang J; Shi X; Yamashita T; Hishikawa N; Takemoto M; Morihara R; Nakano Y; Ohta Y; Deguchi K; Ikeda M; Ikeda Y; Okamoto K; Shoji M; Takatama M; Kojo M; Kuroda T; Ono K; Kimura N; Matsubara E; Osakada Y; Wakutani Y; Takao Y; Higashi Y; Asada K; Senga T; Lee LJ; Tanaka K
J Alzheimers Dis; 2020; 73(1):217-227. PubMed ID: 31771070
[TBL] [Abstract][Full Text] [Related]
34. Iron regulatory protein 2 is involved in brain copper homeostasis.
Mueller C; Magaki S; Schrag M; Ghosh MC; Kirsch WM
J Alzheimers Dis; 2009; 18(1):201-10. PubMed ID: 19584448
[TBL] [Abstract][Full Text] [Related]
35. Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults.
Mangialasche F; Solomon A; Kåreholt I; Hooshmand B; Cecchetti R; Fratiglioni L; Soininen H; Laatikainen T; Mecocci P; Kivipelto M
Exp Gerontol; 2013 Dec; 48(12):1428-35. PubMed ID: 24113154
[TBL] [Abstract][Full Text] [Related]
36. Serum SHBG Levels are not Associated with Longitudinal Cognitive Decline in Mild Cognitive Impairment.
Lin KA; Rundel C; Doraiswamy PM;
J Alzheimers Dis; 2017; 55(3):1123-1130. PubMed ID: 27767986
[TBL] [Abstract][Full Text] [Related]
37. Decreased levels of circulating adiponectin in mild cognitive impairment and Alzheimer's disease.
Teixeira AL; Diniz BS; Campos AC; Miranda AS; Rocha NP; Talib LL; Gattaz WF; Forlenza OV
Neuromolecular Med; 2013 Mar; 15(1):115-21. PubMed ID: 23055000
[TBL] [Abstract][Full Text] [Related]
38. Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease.
Mattsson N; Andreasson U; Zetterberg H; Blennow K;
JAMA Neurol; 2017 May; 74(5):557-566. PubMed ID: 28346578
[TBL] [Abstract][Full Text] [Related]
39. Poor decision making is a consequence of cognitive decline among older persons without Alzheimer's disease or mild cognitive impairment.
Boyle PA; Yu L; Wilson RS; Gamble K; Buchman AS; Bennett DA
PLoS One; 2012; 7(8):e43647. PubMed ID: 22916287
[TBL] [Abstract][Full Text] [Related]
40. Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia.
Yew B; Nation DA;
Brain; 2017 Jul; 140(7):1987-2001. PubMed ID: 28575149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
